Assay-related differences in SuPAR levels: implications for measurement and data interpretation
- PMID: 35567697
- PMCID: PMC9106999
- DOI: 10.1007/s40620-022-01344-7
Assay-related differences in SuPAR levels: implications for measurement and data interpretation
Keywords: Olink; Quantikine; SOMAScan; Soluble urokinase plasminogen activator receptor; Virogates; suPARnostic.
Conflict of interest statement
SSH and JR are scientific advisory board members of Walden Biosciences Inc.
References
-
- Winnicki W, Sunder-Plassmann G, Sengolge G, Handisurya A, Herkner H, Kornauth C, et al. Diagnostic and prognostic value of soluble urokinase-type plasminogen activator receptor (suPAR) in Focal segmental glomerulosclerosis and impact of detection method. Sci Rep. 2019;9(1):13783. doi: 10.1038/s41598-019-50405-8. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- KL2TR002490/TR/NCATS NIH HHS/United States
- T32 HL007853/HL/NHLBI NIH HHS/United States
- U01-DK119083/DK/NIDDK NIH HHS/United States
- HHSN268201800014C/HL/NHLBI NIH HHS/United States
- R01HL153384/HL/NHLBI NIH HHS/United States
- HHSN268201800012I/HL/NHLBI NIH HHS/United States
- HHSN268201800011C/HL/NHLBI NIH HHS/United States
- KL2 TR002490/TR/NCATS NIH HHS/United States
- T32HL129982/HL/NHLBI NIH HHS/United States
- HHSN268201800015I/HB/NHLBI NIH HHS/United States
- HHSN268201800010I/HB/NHLBI NIH HHS/United States
- HHSN268201800011I/HB/NHLBI NIH HHS/United States
- R01 DK109720/DK/NIDDK NIH HHS/United States
- R01 HL132947/HL/NHLBI NIH HHS/United States
- HHSN268201800012C/HL/NHLBI NIH HHS/United States
- T32-HL007853/HL/NHLBI NIH HHS/United States
- HHSN268201800014I/HB/NHLBI NIH HHS/United States
- R01HL132947/HL/NHLBI NIH HHS/United States
- R01-DK109720/DK/NIDDK NIH HHS/United States
- R01 HL153384/HL/NHLBI NIH HHS/United States
- HHSN268201800013I/MD/NIMHD NIH HHS/United States
LinkOut - more resources
Full Text Sources